Zobrazeno 1 - 10
of 45
pro vyhledávání: '"F. S. Habib"'
Publikováno v:
Bulletin of Pharmaceutical Sciences. Assiut.
The objective of the current study was preparation of ketorolac tromethamine (KT) loaded nanoparticles (NPs) based on two polymers (Eudragit RL 100 and Gelatin) for ocular applications providing a controlled drug release to improve KT bioavailability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2dfd27f5b1f1ee1afd5a8b47ee18a70
https://doi.org/10.21608/bfsa.2020.24547.1007
https://doi.org/10.21608/bfsa.2020.24547.1007
Autor:
Shaheer Maher, Andreas Evdokiou, Ye Wang, Tushar Kumeria, Gagandeep Kaur, Gihan Fetih, F. S. Habib, Abel Santos, Dusan Losic, Dina Fathalla
Publikováno v:
Advanced Healthcare Materials. 5:2667-2678
Drug delivery using synthetic nanoparticles including porous silicon has been extensively used to overcome the limitations of chemotherapy. However, their synthesis has many challenges such as lack of scalability, high cost, and the use of toxic mate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b289d301465c5ef225589da3765c5887
https://doi.org/10.1002/adhm.201600688
https://doi.org/10.1002/adhm.201600688
Autor:
Dina F. Mohamed, Sergey L. Bud'ko, F. S. Habib, Giovanni M. Pauletti, Sarah J. Potter, Donglu Shi, Ayat A. Allam
Publikováno v:
International journal of pharmaceutics. 548(1)
Poor aqueous solubility, chemical instability, and indiscriminate cytotoxicity have limited clinical development of camptothecin (CPT) as potent anticancer therapeutic. This research aimed at fabricating thermoresponsive nanocomposites that enhance s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9756e116f6c633723691d29475bd1f54
https://pubmed.ncbi.nlm.nih.gov/29981895
https://pubmed.ncbi.nlm.nih.gov/29981895
Autor:
F. S. Habib, Mohammed Alsawat, Dina Fathalla, Shaheer Maher, Gihan Fetih, Tushar Kumeria, Abel Santos, Dusan Losic
Publikováno v:
Advanced Functional Materials. 25:5107-5116
Current development of drug microcarriers is mainly based on spherical shapes, which are not biologically favorable geometries for complex interactions with biological systems. Scalable synthesis of drug carriers with nonspherical and anisotropic sha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6bf1db147eec8e98c4e3b6f3252383b
https://doi.org/10.1002/adfm.201501249
https://doi.org/10.1002/adfm.201501249
Publikováno v:
Cornea. 31:126-129
Purpose To study the clinical effect of a topical controlled-release ophthalmic fluconazole liposomal formulation on patients with Candida keratitis. Methods Eleven eyes of 11 patients with Candida albicans corneal fungal infection (proved by culture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28b631aef5b561c92bbad16c0e7c3b0
https://doi.org/10.1097/ico.0b013e318221cf12
https://doi.org/10.1097/ico.0b013e318221cf12
Publikováno v:
Scopus-Elsevier
Diclofenac is a synthetic, non-steroidal anti-inflammatory and analgesic compound. It is used topically to treat many inflammatory ocular conditions. However, the poor aqueous solubility of its acidic undissociated form, Diclofenac acid (DA), limits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ffb8d8f183030652c417dcee30cc0c6
https://doi.org/10.1016/s1773-2247(11)50078-4
https://doi.org/10.1016/s1773-2247(11)50078-4
Publikováno v:
Acta Ophthalmologica. 88:901-904
Acta Ophthalmol. 2010: 88: 901–904 Abstract. Purpose: To study the clinical effect of topical controlled-release ophthalmic fluconazole liposomal formulation and to compare its effect with fluconazole solution in a reproducible model of Candida ker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20c4d16b0d8dd4bff4fffb4951a01ef
https://doi.org/10.1111/j.1755-3768.2009.01584.x
https://doi.org/10.1111/j.1755-3768.2009.01584.x
Publikováno v:
Bulletin of Pharmaceutical Sciences. Assiut. 33:59-68
Lornoxicam as a non-steroidal anti-inflammatory drug (NSAID) has the same side effects of this group if taken orally (GIT, renal, and hepatic disorders). Lornoxicam and its metabolites bind extensively to plasma albumin (99%), beside that, it has a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2130b64d32ac3b0b58c78e7cdbfdb6f1
https://doi.org/10.21608/bfsa.2010.147025
https://doi.org/10.21608/bfsa.2010.147025
Publikováno v:
Bulletin of Pharmaceutical Sciences. Assiut. 32:257-271
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0191f720aba911de4cd6585535adc7f9
https://doi.org/10.21608/bfsa.2009.63367
https://doi.org/10.21608/bfsa.2009.63367
Publikováno v:
Bulletin of Pharmaceutical Sciences. Assiut. 31:249-263
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70ffe19cf35912bc0578e7c22613d19b
https://doi.org/10.21608/bfsa.2008.64327
https://doi.org/10.21608/bfsa.2008.64327